고려비엔피

검색하기
기본과 원칙을 중시하는 기업 고려비엔피는 동물의 건강을 생각합니다.
  • 질병예방
  • 동물치료
  • 동물영양
  • 동물환경
  • 컨텐츠로이동

회사소개

HOME Company KBNP History

KBNP History

고려비엔피의 발자취를 확인해보세요.
  • 2020
    • JUN
      • - Patent registered (Patent No. 10-2125235: New Bacteriophage for Prevention
         and Treating the Chicken Escherichia coli and Antibacterial Compositions Containing the Same)
      • - Patent registered (Patent No. 10-2116712: FORMULATIONS FOR CANINE
         HEART DISEASE CONTAINING ORAL DOSING FORMULATIONS WITH HIGHLY PALATABLE EXCIPIENTS)
    • APR
      • - Patent registered (Patent No. 10-2099825: COMPOSITIONS FOR
         CONTROLLING POULTRY RED MITE COMPRISING EXTRACTS DERIVED FROM NATURAL MATERIALS AND PREPARATION METHOD OF THE SAME
  • 2019
    • DEC
      • - Awarded Self-Audit prize for KVGMP by APQA
    • FEB
      • - Awarded merit prize for export by KAHPA
  • 2018
    • DEC
      • - Awarded Self-Audit prize for KVGMP by APQA
    • APR
      • - Patent registered (Patent No. 10-1854164: Veterinary composition for
         reduction vaccine stress and feed compositions for alleviating of vaccine stress symptom)
      • - Awarded Best Companies for Regional Win-win Development prize in
        Yesan-gun
    • JAN
      • - Awarded Best procurement enterprise prize by Public Procurement Service
  • 2017
    • OCT
      • - Awarded the Top Enterprise Grand prize by Chungnam provincial government
    • AUG
      • - Patent registered (Patent No. 10-1774863: Salmonella enteritidis
        mutant strains HID2092 and HID2114 and
        pharmaceutical composition using the same)
    • JUN
      • - Patent registered (Patent No. 10-1753842: A sustained-release
         formulation comprising a fluoroquinolone antibiotics
        and a method for manufacturing the same)
    • JAN
      • - Patent registered (Patent No. 10-1695440: A veterinary composition
        comprising sustained release antibiotics formulation and a
         manufacturing method for the same)
  • 2016
    • JUN
      • - Designated as a KICOX global leading corporation
    • MAY
      • - Patent registered in Vietnam (Patent No. 15504: Attenuated recombinant
         Newcastle disease virus and vaccine containing the same)
      • - Designated as a Global Hidden Champion
  • 2015
    • DEC
      • - Awarded by the Minister of Trade, Industry and Energy
      • - Awarded by the head of the Korea International Trade Association
  • 2014
    • NOV
      • - Patent registered
        (Patent No. 10-1465605: ssrAB, rpoS and hmp-deleted Salmonella Gallinarum and vaccin compositions for Fowl Typhoid comprising the same)
  • 2013
    • DEC
      • - Patent registered
        (Patent No. 10-1341649: Novel lactic acid bacteria having acid resistance, bile-salt resistance and anti-bacterial effect and composition containing the same)
      • - Patent registered
        (Patent No. 10-1345653: Compositions comprising sophora subprostrata extracts for inhibiting the activity of Acetylcholinesterase
    • SEP
      • - Patent registered
        (Patent No. 10-1104911: Avirulent infectious bursal disease variant virus and use as a vaccine)
    • AUG
      • - Patent registered
        (Patent No. 10-1298215: Vaccine composition for immunocastration comprising STF2-GnRH fusion recombinant protein and method for animal immunocastration using the same)
    • APR
      • - Patent registered
        (Patent No. 10-1253505: Novel Ferritin Having Iron-binding Activity and Gene Encoding the Same)
    • MAR
      • - Patent registered in China (ZL 2006 8 0056436.6: Attenuated
        recombinant Newcastle disease virus and vaccine containing the same)
      • - Patent registered in Japan
        (5216012: Attenuated recombinant Newcastle disease virus and vaccine containing the same)
  • 2012
    • JUL
      • - Recognized a technology innovative company
           (INNO-BIZ)
    • MAY
      • - Patent registered
        (Patent No. 10-1150847: Vaccine composition for streptococcus in fisheries)
      • - Patent registered in the United States
        (US 8,173,136 B2: Attenuated recombinant Newcastle disease virus and vaccine containing the same)
    • MAR
      • - Patent registered in Japan
        (4953256: HN epitope recognized by avian immune system and antigenic variant Newcastle disease viruses carrying changes in the epitope)
  • 2011
    • OCT
      • - Patent registered in the United States
        (US 8,029,801 B2 : HN epitope recognized by avian immune system and antigenic variant Newcastle disease viruses carrying changes in the epitope)
      • - Patent registered
        (Patent No. 10-1080015: A vaccine for animal immunocastration comprising CTLA-4-GnRH or GM-CSF-GnRH recombinant protein as an active ingredient)
    • SEP
      • - Patent registered
        (Patent No. 10-1071374: Development of liquid type counteragent for acidity stabilization in ruminant stomach)
    • AUG
      • - Patent registered
        (Patent No. 10-1054947: Disinfectant effervescent tablet
    • JUL
      • - Designated as a Chungnam small giant company – by the governor of
           Chungcheongnam-do
  • 2010
    • JUN
      • - Appointed as Excellent culture company for labor and management by
          Ministry of Labor
  • 2009
    • DEC
      • - Awarded the Special Achievement Award of Export company by NVRQS
      • - Five Serial Winning the prize for KVGMP by NVRQS
      • - Received citation by Korean Knowledge and Economy Minister
  • 2008
    • DEC
      • Win the excellence prize for KVGMP by NVRQS.
    • SEP
      • Win the Grand prize for Technology by Chungnam provincial government
  • 2007
    • DEC
      • - Win the excellence prize for KVGMP by NVRQS
  • 2006
    • DEC
      • - Win the excellence prize for KVGMP by NVRQS
    • SEP
      • - Appointed as a ‘Venture Company’ from KIBO Technology Fund
    • JUL
      • - Certified as a ‘Inno-Biz’(Innovation and Business) Company from Small
           and medium Business Administration.
    • JUN
      • - Appointed as a ‘Promising Small and Medium Company for the export'    from Export Supporting Center Daejeon & Chungnam branch for Small
           and Medium Company
    • FEB
      • - Approved IS0 14001 (Environmental Management System Standard)
  • 2005
    • DEC
      • - Win the excellence prize for KVGMP by NVRQS
    • SEP
      • - Appointed as a Superior Technology Company from Korea Technology
          Guarantee Fund
  • 2004
    • NOV
      • - Opened Clinical Diagnostics Laboratory
  • 2003
    • DEC
      • - Constructed New Biologicals and Injectables plant
    • SEP
      • - Established KBNP Technology Institute
    • AUG
      • - Appointed as a promising export company
    • JUN
      • - Appointed as a "Clean enterprise" from Korea Occupational
          Safety&Healthy Agency
  • 2002
    • JUN
      • - Acquired KVGMP for Biologicals, Feed additives, Water soluble powder,
          Oral solution and Injectables
    • APR
      • - Launched Himmvac® (Animal Vaccine Brand in KBNP)
  • 2001
    • DEC
      • - Changed company name to KBNP, INC. Moved pharmaceutical plant
           into Yesan
    • NOV
      • - Purchased vaccine production business from Bayer Korea Ltd.
  • 1998
    • DEC
      • Licensed to manufacture Supplemental Feed
  • 1994
    • JAN
      • Acquired by Current Management Team
  • 1988
    • JAN
      • - Established Korea Vetchem Co, Ltd.